Walid Kamoun, Vice President, Global Head of R&D Oncology at Servier, shared on LinkedIn:
“There is something powerful about seeing an entire global team come together around one shared purpose.
Over two days in the south of Paris, our Servier Oncology Therapeutic Area came together for reflection, discussion, networking, and, of course, some fun.
Colleagues travelled from the US, Europe and APAC, bringing different perspectives, expertise and experiences, but united by one ambition: to bring transformative therapies to people living with cancer.
Looking around the room, I was reminded of how remarkable the Servier Oncology journey has already been.
But what excites me most is that this is only the beginning.
There is more science to explore.
More innovation to unlock.
More collaboration to build.
And ultimately, many more patients who need better therapeutic options.
Our commitment to them remains unwavering. A huge thank you to everyone who made these two days so special.
Proud of what we have built together, and even more excited about what comes next.
Thanks to the organizing committee for an increadible job building a balanced and engaging agenda.”
Other articles about Servier on OncoDaily.
